T1	Outcomes 249 267	stage III melanoma
T2	Outcomes 1136 1157	Median follow-up time
T3	Outcomes 1227 1241	Median OS time
T4	Outcomes 1306 1323	Five-year OS rate
T5	Outcomes 1358 1407	Estimated 5-year relapse-free survival (RFS) rate
T6	Outcomes 1503 1538	incidence of serious adverse events
T7	Outcomes 1607 1632	neuropsychiatric toxicity
